1. Home
  2. GRBK vs OGN Comparison

GRBK vs OGN Comparison

Compare GRBK & OGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GRBK
  • OGN
  • Stock Information
  • Founded
  • GRBK N/A
  • OGN 1923
  • Country
  • GRBK United States
  • OGN United States
  • Employees
  • GRBK N/A
  • OGN N/A
  • Industry
  • GRBK Homebuilding
  • OGN Biotechnology: Pharmaceutical Preparations
  • Sector
  • GRBK Consumer Discretionary
  • OGN Health Care
  • Exchange
  • GRBK Nasdaq
  • OGN Nasdaq
  • Market Cap
  • GRBK 3.4B
  • OGN 2.7B
  • IPO Year
  • GRBK N/A
  • OGN N/A
  • Fundamental
  • Price
  • GRBK $64.66
  • OGN $10.01
  • Analyst Decision
  • GRBK Buy
  • OGN Buy
  • Analyst Count
  • GRBK 2
  • OGN 3
  • Target Price
  • GRBK $71.00
  • OGN $17.33
  • AVG Volume (30 Days)
  • GRBK 255.6K
  • OGN 3.6M
  • Earning Date
  • GRBK 10-29-2025
  • OGN 10-30-2025
  • Dividend Yield
  • GRBK N/A
  • OGN 0.78%
  • EPS Growth
  • GRBK 7.68
  • OGN N/A
  • EPS
  • GRBK 7.83
  • OGN 2.69
  • Revenue
  • GRBK $2,137,742,000.00
  • OGN $6,281,000,000.00
  • Revenue This Year
  • GRBK N/A
  • OGN N/A
  • Revenue Next Year
  • GRBK $6.60
  • OGN $0.79
  • P/E Ratio
  • GRBK $8.82
  • OGN $3.82
  • Revenue Growth
  • GRBK 13.87
  • OGN N/A
  • 52 Week Low
  • GRBK $50.57
  • OGN $8.01
  • 52 Week High
  • GRBK $84.66
  • OGN $19.05
  • Technical
  • Relative Strength Index (RSI)
  • GRBK 34.45
  • OGN 43.99
  • Support Level
  • GRBK $69.33
  • OGN $10.05
  • Resistance Level
  • GRBK $77.93
  • OGN $11.29
  • Average True Range (ATR)
  • GRBK 2.07
  • OGN 0.34
  • MACD
  • GRBK -0.90
  • OGN -0.08
  • Stochastic Oscillator
  • GRBK 0.00
  • OGN 0.39

About GRBK Green Brick Partners Inc.

Green Brick Partners Inc is a homebuilding and land development company. It acquires and develops land, as well as provides land and construction financing to its controlled builders. The company has three reportable segments: builder operations central, builder operations southeast, and land development. The majority of the company's revenue is generated from the builder operations central segment which is entirely the operations of builders in Texas. The company is engaged in various aspects of the homebuilding process, including land acquisition and development, entitlements, design, construction, marketing, sales, and brand image creation. In addition to homebuilding, the company provides home financing services, such as mortgage and title.

About OGN Organon & Co.

Organon & Co is a science-based pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada followed by the United States and then Asia Pacific and Japan. The company generates the majority of its revenue from the Established Brands product portfolio.

Share on Social Networks: